This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations by Nick Smartt in Drug Delivery Systems
Introduction
Nick Smartt is an accomplished inventor based in Melbourne, GB. He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent that enhances the efficiency of fluid delivery.
Latest Patents
Nick Smartt holds a patent for an "Arrangement for sequential delivery of fluid volumes." This invention relates to a reservoir unit designed for a drug delivery arrangement. The reservoir unit comprises a housing adapted to accommodate a fluid substance, featuring a displaceable wall. It includes a fluid transport member with a fluid outlet, first fluid communication means for connecting with another reservoir, and second fluid communication means for interaction with the housing's interior. Additionally, the coupling means are designed for connection with mating coupling means associated with the other reservoir. The invention also encompasses a drug delivery arrangement employing this reservoir unit, where the fluid transport member is a needle fixedly retained by the outlet portion, featuring a side hole in the needle body just proximally of the outlet portion.
Career Highlights
Nick Smartt is currently associated with Novo Nordisk A/S, a leading global healthcare company. His work focuses on developing innovative solutions that improve drug delivery methods, thereby enhancing patient care and treatment outcomes.
Collaborations
Throughout his career, Nick has collaborated with notable professionals in the field, including Thomas Lindblad and Klaus Bendix. These collaborations have contributed to the advancement of drug delivery technologies.
Conclusion
Nick Smartt's innovative contributions to drug delivery systems exemplify the importance of advancements in medical technology. His patent reflects a commitment to improving healthcare solutions, ultimately benefiting patients worldwide.
